Cargando…
Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals
Fe(3)O(4)-Au hybrid nanoparticles (HNPs) have shown increasing potential for biomedical applications such as image guided stimuli responsive drug delivery. Incorporation of the unique properties of HNPs into thermally responsive scaffolds holds great potential for future biomedical applications. Her...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645763/ https://www.ncbi.nlm.nih.gov/pubmed/23603890 http://dx.doi.org/10.3390/ijms14048585 |
_version_ | 1782268540506603520 |
---|---|
author | Roach, Paul McGarvey, David J. Lees, Martin R. Hoskins, Clare |
author_facet | Roach, Paul McGarvey, David J. Lees, Martin R. Hoskins, Clare |
author_sort | Roach, Paul |
collection | PubMed |
description | Fe(3)O(4)-Au hybrid nanoparticles (HNPs) have shown increasing potential for biomedical applications such as image guided stimuli responsive drug delivery. Incorporation of the unique properties of HNPs into thermally responsive scaffolds holds great potential for future biomedical applications. Here we successfully fabricated smart scaffolds based on thermo-responsive poly(N-isopropylacrylamide) (pNiPAM). Nanoparticles providing localized trigger of heating when irradiated with a short laser burst were found to give rise to remote control of bulk polymer shrinkage. Gold-coated iron oxide nanoparticles were synthesized using wet chemical precipitation methods followed by electrochemical coating. After subsequent functionalization of particles with allyl methyl sulfide, mercaptodecane, cysteamine and poly(ethylene glycol) thiol to enhance stability, detailed biological safety was determined using live/dead staining and cell membrane integrity studies through lactate dehydrogenase (LDH) quantification. The PEG coated HNPs did not show significant cytotoxic effect or adverse cellular response on exposure to 7F2 cells (p < 0.05) and were carried forward for scaffold incorporation. The pNiPAM-HNP composite scaffolds were investigated for their potential as thermally triggered systems using a Q-switched Nd:YAG laser. These studies show that incorporation of HNPs resulted in scaffold deformation after very short irradiation times (seconds) due to internal structural heating. Our data highlights the potential of these hybrid-scaffold constructs for exploitation in drug delivery, using methylene blue as a model drug being released during remote structural change of the scaffold. |
format | Online Article Text |
id | pubmed-3645763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-36457632013-05-13 Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals Roach, Paul McGarvey, David J. Lees, Martin R. Hoskins, Clare Int J Mol Sci Article Fe(3)O(4)-Au hybrid nanoparticles (HNPs) have shown increasing potential for biomedical applications such as image guided stimuli responsive drug delivery. Incorporation of the unique properties of HNPs into thermally responsive scaffolds holds great potential for future biomedical applications. Here we successfully fabricated smart scaffolds based on thermo-responsive poly(N-isopropylacrylamide) (pNiPAM). Nanoparticles providing localized trigger of heating when irradiated with a short laser burst were found to give rise to remote control of bulk polymer shrinkage. Gold-coated iron oxide nanoparticles were synthesized using wet chemical precipitation methods followed by electrochemical coating. After subsequent functionalization of particles with allyl methyl sulfide, mercaptodecane, cysteamine and poly(ethylene glycol) thiol to enhance stability, detailed biological safety was determined using live/dead staining and cell membrane integrity studies through lactate dehydrogenase (LDH) quantification. The PEG coated HNPs did not show significant cytotoxic effect or adverse cellular response on exposure to 7F2 cells (p < 0.05) and were carried forward for scaffold incorporation. The pNiPAM-HNP composite scaffolds were investigated for their potential as thermally triggered systems using a Q-switched Nd:YAG laser. These studies show that incorporation of HNPs resulted in scaffold deformation after very short irradiation times (seconds) due to internal structural heating. Our data highlights the potential of these hybrid-scaffold constructs for exploitation in drug delivery, using methylene blue as a model drug being released during remote structural change of the scaffold. Molecular Diversity Preservation International (MDPI) 2013-04-19 /pmc/articles/PMC3645763/ /pubmed/23603890 http://dx.doi.org/10.3390/ijms14048585 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Roach, Paul McGarvey, David J. Lees, Martin R. Hoskins, Clare Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals |
title | Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals |
title_full | Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals |
title_fullStr | Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals |
title_full_unstemmed | Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals |
title_short | Remotely Triggered Scaffolds for Controlled Release of Pharmaceuticals |
title_sort | remotely triggered scaffolds for controlled release of pharmaceuticals |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3645763/ https://www.ncbi.nlm.nih.gov/pubmed/23603890 http://dx.doi.org/10.3390/ijms14048585 |
work_keys_str_mv | AT roachpaul remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals AT mcgarveydavidj remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals AT leesmartinr remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals AT hoskinsclare remotelytriggeredscaffoldsforcontrolledreleaseofpharmaceuticals |